AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

List of Jeeva TeleVisits Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Frantz Viral Therapeutics Life Sciences 10 $1M United States Jeeva Clinical Trials Jeeva TeleVisits Collaboration 2024 n/a
In 2024, Frantz Viral Therapeutics centralized clinical operations on Jeeva Clinical Trials, deploying Jeeva EDC/CTMS to manage multi-site Phase II cancer-prevention trials in the United States. The deployment included Jeeva TeleVisits as the remote patient engagement and video visits component, with Jeeva TeleVisits aligned to the platform's documented patient engagement and remote-visit capabilities, and categorized under Collaboration. The implementation focused on EDC and CTMS capabilities, with explicit use of Jeeva EDC/CTMS for study configuration, electronic data capture, and trial management workflows across participating sites. Functional scope included standardized study configuration and centralized data workflows, and the solution’s patient engagement module was used to support remote visit scheduling and virtual encounter capture. Operational coverage was the clinical operations function for multi-site Phase II cancer-prevention trials in the United States, impacting study coordination, data management, and patient engagement processes. Governance emphasis centered on centralizing configuration and standardizing data workflows across sites, which improved study configuration and data workflows as reported.
Immunoact Life Sciences 150 $8M India Jeeva Clinical Trials Jeeva TeleVisits Collaboration 2023 n/a
In 2023, Immunoact deployed Jeeva TeleVisits with vendor Jeeva Clinical Trials to support clinical operations and data management for CAR-T cell and gene-therapy trials across India. Jeeva TeleVisits, classified as Collaboration, was configured to manage electronic clinical outcome assessments and electronic consenting workflows, and to deliver video consenting and patient engagement capabilities required for these studies. The implementation centered on eCOA and eConsent modules, with video consenting instrumented as a primary engagement channel for remote and onsite patient interactions. Jeeva TeleVisits was used to capture regulated clinical data and consent artifacts, aligning electronic capture, timestamping, and storage policies with India regulatory data-storage requirements. Operational coverage included Immunoact clinical operations and data management teams across India, focusing on trial subject enrollment, consent capture, and ongoing patient engagement for cell and gene therapy protocols. Governance changes emphasized compliant digital consent workflows and centralized electronic data capture for monitoring and audit readiness, leveraging Jeeva TeleVisits to unify consent and patient communication within the Collaboration application.
Taxa Technologies Life Sciences 10 $1M United States Jeeva Clinical Trials Jeeva TeleVisits Collaboration 2024 n/a
In 2024, Taxa Technologies engaged Jeeva Clinical Trials to deploy Jeeva TeleVisits, using Collaboration software to operationalize decentralized clinical visits in the United States. The engagement targeted clinical study patient engagement and decentralized visits to support recruitment and retention. Taxa implemented Jeeva TeleVisits together with Jeeva patient-engagement and eCOA capabilities, applying video-visit workflows, remote assessment scheduling, and electronic clinical outcome assessment capture to virtualize site to patient interactions. Configuration work emphasized visit typology, patient messaging templates, and appointment orchestration to align with study visit windows and protocol requirements. These Collaboration capabilities were used to manage consent touchpoints, automated visit reminders, and eCOA data collection within remote visit workflows. Operational coverage extended to study teams, site coordinators, and patient participants across United States sites, integrating TeleVisits into site scheduling and study visit protocols. Governance focused on standardizing visit procedures, defining study level scheduling rules, and establishing patient engagement protocols to support decentralized clinical operations. Jeeva TeleVisits provided Collaboration support for Taxa Technologies clinical operations, with the deployment explicitly leveraged to improve recruitment and retention by reducing in person visit burden and enabling remote follow up.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Jeeva TeleVisits

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Jeeva TeleVisits. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Jeeva TeleVisits Coverage

Jeeva TeleVisits is a Collaboration solution from Jeeva Clinical Trials.

Companies worldwide use Jeeva TeleVisits, from small firms to large enterprises across 21+ industries.

Organizations such as Immunoact, Taxa Technologies and Frantz Viral Therapeutics are recorded users of Jeeva TeleVisits for Collaboration.

Companies using Jeeva TeleVisits are most concentrated in Life Sciences, with adoption spanning over 21 industries.

Companies using Jeeva TeleVisits are most concentrated in India and United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Jeeva TeleVisits across Americas, EMEA, and APAC.

Companies using Jeeva TeleVisits range from small businesses with 0-100 employees - 66.67%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 0%.

Customers of Jeeva TeleVisits include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Jeeva TeleVisits customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Collaboration.